Skip to main content
Pharmedi Vietnam

28-30 September 2027
Ho Chi Minh City, Vietnam

Vietnam healthcare
market
to the world

JOINSTAR BIOMEDICAL TECHNOLOGY CO.,LTD.

JOINSTAR BIOMEDICAL TECHNOLOGY CO.,LTD.

Booth P27

NO.519,XingGuo RD.,Yuhang Economic and Technological Development Zone, Hangzhou , Zhejiang, China, 311188

JOINSTAR is the world's first company to provide advanced diagnostic tests for the early diagnosis, prediction, monitoring and prognostic management of sepsis. Our tests enable hospitals and laboratories to provide that information quickly and reliably. HBP (Heparin Binding Protein), a novel biomarker, research shows that HBP is an early diagnostic marker of infection-associated organ dysfunction and can reliably predict whether a patient with infection will progress to severe sepsis within 72 hours